南财智讯1月29日电，美农生物在投资者关系活动中表示，公司实施"分种分品、全程营养"产品战略， 投资建设"年产10万吨玉米蛋白精加工项目"是依托全资子公司成都美溢德的酶解技术平台，充分利用当 地优质玉米副产品供应优势，开展规模化生产；项目将巩固公司在饲料酶解蛋白领域的竞争优势，推动 客户主体从猪品类向水产和家禽拓展，落实猪、水产、家禽、反刍并重的产品战略，增强市场竞争力并 带来新增长点。 ...

Core Viewpoint - The company emphasizes "innovation-driven development" and focuses on product and technology innovation to address industry pain points and enhance animal production performance while ensuring food safety [1] Group 1: Company Strategy - The company is committed to the development and application research of efficient, safe, and environmentally friendly feed additives and enzymatic protein feed raw materials [1] - The company has been exploring enzymatic technology for various non-grain protein sources such as cottonseed protein, soybean protein, and corn protein [1] Group 2: Product Advantages - Enzymatic protein raw materials have advantages over traditional protein sources in terms of protein digestion and absorption efficiency, as well as improving animal physiological functions [1]